FDA approves 1st mRNA flu shot, from Moderna
The Food and Drug Administration on Wednesday approved the U.S.’s first flu shot that uses mRNA technology: mFlusiva, from drugmaker Moderna. The FDA granted approval for two age groups: adults 50 to 65 and adults 65 and up, on the condition that Moderna run an additional clinical trial in the older group, the company said … Read more